PPT-A Clinical Approach Utilizing GLP-1 RAs

Diabetes Management for the Cardiologist Confidential Do Not Distribute 1 To understand the physiologic relationships between cardiovascular disease CVD and Type 2 Diabetes Mellitus DM and review the statistics behind the risk. to promote literacy in Guatemala. 449 . Rotary . Clubs. 67 Districts . 7 . Countries. 17 Years. The Worldwide GLP Family. 2015 School Year Stats:. 152,000 students benefited. 171 textbook projects . . Lori Walker, Ph.D.. What is the “Triune Brain”?. Tri = ???. Tri = Three. Une. = ???. Une. = One . Triune = . Three parts that make up the one human brain. __________________________________. Veronika Voronova, Kirill . Zhudenkov. , Kirill . Peskov. The 8th Workshop on Mathematical Models and Numerical Methods in Biology and Medicine. INM RAS, Moscow. 01 Nov . 2016. Introduction: diabetes type II pathogenesis. T. ask – . -Please go through the slides and follow the . instructions. Please email TJ your form’s idea on the stretch and challenge task. Tutor time session 5: . Global Gender issues . (as voted for by you!). Program Goal. Case Presentation: Diane. Case Presentation (cont). ADA/EASD Position Statement. ADA/EASD Position Statement: Glycemic Targets. ADA/EASD Position Statement on Therapeutic Options: Lifestyle. Program Overview. Pathophysiology of Hyperglycemia. Updated ADA/EASD Standard of Care, 2017. Delays in Intensification of Therapy. The Role of Basal Insulin and GLP-1 RA in Controlling Hyperglycemia. GLP-1 RAs in Combination With Basal Insulin Approved by US FDA. Why Combine a GLP-1 RA With Basal Insulin?. Adding Prandial Insulin to Basal Insulin . Exenatide Once Weekly Now Approved for Use With Basal Insulin. Insulin and Incretins: the perfect Partnership? Stephen Colagiuri, MD Professor of Metabolic Health Boden Institute of Obesity, Nutrition and Exercise University of Sydney Sydney, Australia Moderator ForkheadbRZQORDGHGIURPLRVFLHQWLILFDFRPDW0YLDIUHHDFFHVVOnonehandphosphorylationofFOXOproteinsinresponsetogrowthfactorssuchasinsulin-likegrowthfactor-IIGF-IerythropoietinepidermalgrowthfactorEGFornerveg Part I. F. . Hosseinpanah. Obesity Research Center. Research Institute for Endocrine sciences. Shahid. . Beheshti. University. of Medical Sciences. November 23, 2014. The incretin effect. Up to 70% of post-glucose insulin secretion is due to the effects of incretins. What Follows Metformin? . James R. Gavin III, MD, PhD. CEO & Chief Medical Officer, Healing Our Village, Inc.. Clinical Professor of Medicine. Emory University, School of Medicine. Atlanta, Georgia USA. )JOEBXJ 7PMVNF\r"SUJDMF*%\rQBHFT Fivebroadtypeshavebeenidentiedasexcitatory,inhibi-tory,secretomotor,vasomotor,andneuronsinnervatingen OVERVIEW 4080120160200240280320360400440480Analyte Conc. / IS Conc. 0.01.02.03.04.05.06.07.08.08.9AnalyteArea /IS Area 2.052.152.252.352.452.552.652.752.852.953.053.15 1000200030004000500060006283Inte November 2016. Andrew Gallagher. Consultant Physician. and Endocrinologist. NHS Greater Glasgow & Clyde. Prevalence – 2015 data. WORLDWIDE. . Almost 300 million people with diabetes aged 20-79.